IRD · Opus Genetics, Inc. · Proposed Sales
$4.27
+0.34 (+8.65%)
At close · Nov 4
Return incl. dividend (before tax)
Market Cap
$326.96M
Shares
83.20M
Volume · Nov 4
1.16M
Avg daily vol (3M)
2.48M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-11-03 | Magrath George | Officer | 28,258 | 2026-11-03 | Raymond James & Associates, Inc. |
| 2026-10-23 | Gagnon Robert E. | Officer | 14,000 | 2026-10-23 | Jefferies LLC |
| 2026-10-23 | YERXA BENJAMIN R | Officer | 33,189 | 2026-10-23 | Raymond James & Associates, Inc. |
| 2026-10-23 | Magrath George | Officer | 9,591 | 2026-10-23 | Raymond James & Associates, Inc. |
| 2026-09-03 | Gagnon Robert E. | Officer | 28,000 | 2026-09-03 | Jefferies LLC |
| 2026-07-23 | SCHACHLE JOSEPH K | Officer | 4,644 | 2026-07-23 | Raymond James & Associates |
| 2026-07-23 | Magrath George | Officer | 9,475 | 2026-07-23 | Jefferies LLC |
| 2026-07-23 | YERXA BENJAMIN R | Officer | 7,429 | 2026-07-23 | Raymond James & Associates |
| 2026-07-23 | Gagnon Robert E. | Officer | 7,783 | 2026-07-23 | Jefferies LLC |
| 2026-04-23 | YERXA BENJAMIN R | Officer | 7,470 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Jayagopal Ashwath | Officer | 7,542 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | SCHACHLE JOSEPH K | Officer | 4,697 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Gagnon Robert E. | Officer | 7,842 | 2026-04-23 | Raymond James & Associates |
| 2026-04-23 | Magrath George | Officer | 9,511 | 2026-04-23 | Raymond James & Associates |
| 2026-03-16 | Magrath George | Officer | 24,438 | 2026-03-16 | Raymond James & Associates |
Showing 1–15 of 15 filings
Key facts
CIK
1228627
CUSIP
67577R102
13F (30d)
23 filings
23 filers
Visit website
Investor relations